Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDS
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDS
批准号:
9321162
负责人:
Eliseo A Eugenin
金额:
$47.95万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-07 至 2021-04-30
关键词:
Anti-Retroviral AgentsApoptosisApoptoticAreaAstrocytesAutophagocytosisBiologyBrainCalciumCalcium SignalingCellsCognitive deficitsCommunicationConnexin 43ConnexinsCytoplasmDataDementiaDevelopmentDinoprostoneDockingEnsureExhibitsFunctional disorderFundingGap JunctionsGlutamatesGoalsHIVHIV InfectionsHIV-1HumanImpaired cognitionIn VitroIndividualInflammatoryInositolIonsJournalsLaboratoriesLipidsLiquid substanceMaintenanceMedical centerMedicineMicrogliaMinorMitochondriaMonkeysNeuraxisNeurogliaNeurologicNeurologic DysfunctionsNeuronsPathogenesisPathway interactionsPeer ReviewPeptidesPersonsPlayPopulationPrevalencePrimary InfectionProstaglandinsPublic HealthPublicationsRNARecruitment ActivityResearchResistanceRoleSIVSecond Messenger SystemsSignal TransductionStructureSynapsesTestingTissue SampleTissuesToxic effectUniversitiesVirus Replicationantiretroviral therapybasebrain tissuecollegecytochrome cgap junction channelin vivomacrophagemitochondrial dysfunctionmotor deficitmotor impairmentnervous system disorderneuroAIDSneurotoxicneurotoxicitynew therapeutic targetnovelreceptor sensitivityrelease factorresponsesuccesstraffickingtripolyphosphate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract:
As of 2014, an estimated 35 million persons worldwide were living with human immunodeficiency virus
(HIV). Early after primary infection, HIV enters the CNS and causes long lasting cognitive and motor
impairment in 30-60 % of infected individuals, even in the current antiretroviral era. As infected individuals
are living longer, the prevalence of neurological complications has been increasing. In the CNS, HIV
infects mostly microglia/macrophages, but also a small population of astrocytes. However, despite the key
roles of astrocytes in CNS functions, the role of these cells in NeuroAIDS has been relatively ignored. Our
studies during the last funding period provide strong evidence for the critical role of astrocytes in the
pathogenesis of NeuroAIDS. In particular, we have demonstrated that despite relatively low numbers of
infected astrocytes and low to undetectable HIV replication, the HIV infected astrocytes transmit apoptotic
and inflammatory signals, including calcium and inositol triphosphate (IP3), to neighboring uninfected cells,
promoting neuronal damage and demise. We have also shown that these pro-apoptotic molecules are
spread from the few HIV infected astrocytes via connexin-43 (Cx43) containing gap junctions (GJ) and
unopposed hemichannels (uHC), whose expression and opening is regulated by HIV. Indeed, blocking GJ
or uHC reduced amplification of bystander apoptosis, cellular dysfunction, synaptic compromise, and
mitochondrial dysfunction induced by HIV infected astrocytes. Interestingly, HIV infected astrocytes
themselves are protected from apoptosis by mechanisms that involve altered apoptosome formation and
mitochondrial function. Importantly, we have tested and validated most of the mechanisms operating in
HIV infected astrocytes in vivo in human and monkey brain tissue sections. Thus, based on the results
obtained during the extremely productive period funded by our first R01 (resulting in over 40 publications
in high quality peer reviewed journals) we have formulated our current hypothesis that “HIV infected
astrocytes survive HIV infection to become HIV reservoirs, and that these cells send toxic, pro-apoptotic
signals to surrounding cells via Cx43 containing channels, leading to the CNS dysfunction and
NeuroAIDS”. In this application we propose to characterize the novel pathways of HIV toxicity within the
brain and to identify the role of GJ and uHC in CNS dysfunction. The results obtained from this proposal
will lead to the identification of potential novel therapeutic targets to limit the devastating consequences of
NeuroAIDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic strategies to eliminate CNS Myeloid Viral Reservoirs
-
批准号:10630131
-
项目类别:
-
资助金额:$69.05万
-
财政年份:2021
-
负责人:Eliseo A Eugenin
-
依托单位:
Metabolic strategies to eliminate CNS Myeloid Viral Reservoirs
-
批准号:10458785
-
项目类别:
-
资助金额:$70.55万
-
财政年份:2021
-
负责人:Eliseo A Eugenin
-
依托单位:
Metabolic strategies to eliminate CNS Myeloid Viral Reservoirs
-
批准号:10327167
-
项目类别:
-
资助金额:$55.94万
-
财政年份:2021
-
负责人:Eliseo A Eugenin
-
依托单位:
Role of pannexin-1 hemichannels in NeuroAIDS
-
批准号:10166965
-
项目类别:
-
资助金额:$52.48万
-
财政年份:2018
-
负责人:Eliseo A Eugenin
-
依托单位:
Role of pannexin-1 hemichannels in NeuroAIDS
-
批准号:9271671
-
项目类别:
-
资助金额:$72.01万
-
财政年份:2017
-
负责人:Eliseo A Eugenin
-
依托单位:
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDS
-
批准号:8329102
-
项目类别:
-
资助金额:$37.53万
-
财政年份:2012
-
负责人:Eliseo A Eugenin
-
依托单位:
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDS
-
批准号:9914883
-
项目类别:
-
资助金额:$52.54万
-
财政年份:2012
-
负责人:Eliseo A Eugenin
-
依托单位:
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDS
-
批准号:8826812
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2012
-
负责人:Eliseo A Eugenin
-
依托单位:
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDS
-
批准号:8793824
-
项目类别:
-
资助金额:$22.36万
-
财政年份:2012
-
负责人:Eliseo A Eugenin
-
依托单位:
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDS
-
批准号:8467056
-
项目类别:
-
资助金额:$13.98万
-
财政年份:2012
-
负责人:Eliseo A Eugenin
-
依托单位:
The role of gap junction channels in NeuroAIDS
-
批准号:7767689
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2006
-
负责人:Eliseo A Eugenin
-
依托单位:
The role of gap junction channels in NeuroAIDS
-
批准号:7119807
-
项目类别:
-
资助金额:$12.47万
-
财政年份:2006
-
负责人:Eliseo A Eugenin
-
依托单位:
The role of gap junction channels in NeuroAIDS
-
批准号:7577551
-
项目类别:
-
资助金额:$13.13万
-
财政年份:2006
-
负责人:Eliseo A Eugenin
-
依托单位:
The role of gap junction channels in NeuroAIDS
-
批准号:7194154
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2006
-
负责人:Eliseo A Eugenin
-
依托单位:
The role of gap junction channels in NeuroAIDS
-
批准号:7359634
-
项目类别:
-
资助金额:$12.9万
-
财政年份:2006
-
负责人:Eliseo A Eugenin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: